The UK government has published a much-anticipated Bill which will make significant changes to the UK competition and consumer rules and bolster the powers of the Competition and Markets Authority (CMA). Revised merger...more
The UK government has published a much-anticipated Bill to shake up the competition and consumer regime. Front and centre is a brand new UK digital markets regime. The new rules aim to boost competition in the digital sector...more
2022 saw a mixed picture in terms of antitrust enforcement across the globe. For the jurisdictions surveyed in our report, global fine totals were down significantly from 2021 (USD3.5bn, compared to USD11.3bn), with the U.S.,...more
Nearly a year after the UK Competition and Markets Authority (CMA) announced its Sustainability Taskforce, it has issued for consultation draft guidance to show how businesses can pursue green cooperation without fear of...more
On 20 October 2022, an adviser (Advocate General) to the European Court of Justice (ECJ) recommended that the ECJ uphold the European Commission (EC)’s appeal of a 2020 judgment by the lower-tier General Court (GC), which set...more
This newsletter is a summary of the antitrust developments we think are most interesting to your business. Thomas Masterman, partner based in London, is our editor this month (learn more about Tom in our Q&A feature at the...more
UK competition rules are facing unprecedented levels of change. Last month we reported on the UK Government’s intentions for broad reforms to the competition and consumer law regimes. Now, the Government has set out the...more
Following a consultation in summer 2021, which set out a suite of wide-ranging proposals for reforms to UK competition and consumer laws, the UK Government has now confirmed the changes that it plans to take forward.
...more
The UK Competition and Markets Authority (CMA) has published for consultation its much-anticipated draft guidance on vertical agreements (Draft Guidance). ...more
The UK Competition and Markets Authority (CMA) has imposed over GBP260 million in fines on several drug makers for two breaches of competition law: (i) charging excessive and unfair prices, in breach of the Chapter II...more